LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

LLY

1,136.41

-0.5%↓

JNJ

238.85

+0.91%↑

ABBV

225.29

+0.05%↑

UNH

407.06

-1.28%↓

MRK

119

-0.38%↓

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 juin 2026, 23:36 UTC

Résultats

Correction to Oracle Reports Higher 4Q Profit Article

10 juin 2026, 23:19 UTC

Actions en Tendance

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10 juin 2026, 23:09 UTC

Principaux Mouvements du Marché

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10 juin 2026, 23:04 UTC

Résultats

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10 juin 2026, 20:44 UTC

Principaux Mouvements du Marché

Caterpillar Raises Quarterly Dividend 8%

10 juin 2026, 23:49 UTC

Acquisitions, Fusions, Rachats

Elliott: Northern Star Should Take No Options Off The Table

10 juin 2026, 23:48 UTC

Acquisitions, Fusions, Rachats

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10 juin 2026, 23:48 UTC

Acquisitions, Fusions, Rachats

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10 juin 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10 juin 2026, 23:47 UTC

Acquisitions, Fusions, Rachats

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10 juin 2026, 23:46 UTC

Acquisitions, Fusions, Rachats

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10 juin 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10 juin 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 juin 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10 juin 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10 juin 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10 juin 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10 juin 2026, 21:57 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 21:52 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 21:35 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 21:22 UTC

Résultats

Oracle Stock Slides on Increased Capital Spending -- WSJ

10 juin 2026, 20:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

10 juin 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10 juin 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 juin 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 juin 2026, 20:39 UTC

Market Talk
Résultats

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10 juin 2026, 20:34 UTC

Résultats

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10 juin 2026, 20:33 UTC

Résultats

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10 juin 2026, 20:33 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

10 juin 2026, 20:33 UTC

Market Talk
Résultats

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat